Combining electroacupuncture with rTMS to improve movement after stroke
Official title: Efficacy and Safety of Electroacupuncture Combined With rTMS on Motor Function Recovery After Stroke: A Multi-center Randomized Controlled Clinical Study
Run by Fujian University of Traditional Chinese Medicine · NCT07113990 · Data updated 2026-11-12
This study will test whether adding electroacupuncture to rTMS helps adults 2 weeks to 6 months after a first unilateral stroke improve their motor function.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years to 75 Years |
| Sex | All |
| Enrollment | 180 (estimated) |
| Sponsor | Fujian University of Traditional Chinese Medicine Academic / other |
| Locations | 3 sites (Fuzhou, Fujian and 2 other locations) |
| Status | Recruiting |
| Started | August 27, 2025 |
| Main results expected | July 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | November 3, 2026 |
| Trial ID | NCT07113990 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are right-handed adults aged 40–75 with a first unilateral stroke 2 weeks to 6 months earlier and moderate motor impairment who can follow instructions and give informed consent.
✕Probably not a fit
Patients with severe spasticity, major cognitive or language deficits, epilepsy, metallic implants or MRI contraindications, non‑vascular motor causes, pregnancy, or those unable to tolerate TMS/EA are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter randomized controlled trial compares active electroacupuncture plus active repetitive transcranial magnetic stimulation (rTMS) to sham electroacupuncture plus active rTMS in people with recent unilateral stroke. Participants aged 40–75 with moderate motor impairment (Brunnstrom II–IV) receive a standardized rTMS program alongside either real or sham peripheral electrostimulation. Outcomes include clinical motor scales (Fugl-Meyer, ARAT, FAC), kinematic measures, electrophysiology (EEG, EMG, TMS), blood biomarkers, and resting-state fMRI to probe neuroplasticity. The design aims to determine whether combining central (rTMS) and peripheral (EA) stimulation produces greater functional gains and related neurophysiologic changes than rTMS with sham EA.
Why it matters
Potential benefit: If successful, the combined approach could produce faster or larger improvements in arm and leg movement after stroke by enhancing central–peripheral neuroplasticity.
How similar studies have gone: Previous trials show rTMS can aid post-stroke motor recovery and some smaller studies support electroacupuncture, but well-controlled trials combining both approaches are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed with stroke confirmed by neuroimaging (CT/MRI). * First-ever stroke, unilateral hemispheric lesion, related to motor dysfunction. * Age between 40 and 75 years. * Duration from stroke onset between 2 weeks and 6 months. * Brunnstrom stage II-IV. * Right-handed. * Able to understand instructions and voluntarily provide written informed consent. Exclusion Criteria: * History of epilepsy or familial epilepsy. * Motor dysfunction due to non-vascular causes (e.g., tumor, trauma). * Severe aphasia or cognitive impairment (MoCA \< 18). * Severe systemic complications (e.g., severe organ dysfunction, deep vein thrombosis). * Presence of metallic implants or contraindications for MRI. * Severe anxiety (HAMA \> 7) or depression (HAMD \> 8). * Severe spasticity (modified Ashworth ≥ 2). * Fear or intolerance of TMS or electroacupuncture. * Pregnancy, breastfeeding, or concurrent participation in other clinical trials affecting outcomes.
Where it's running
-
Fuzhou University Affiliated Provincial Hospital
Fuzhou, Fujian, China Recruiting -
Fujian Provincial People's Hospital
Fuzhou, Fujian, China Not yet recruiting -
Wenzhou Hospital of Traditional Chinese Medicine
Wenzhou, Zhejiang, China Not yet recruiting
Study contacts
- Study coordinator: Jing Tao, PhD
- Email: taojing01@fjtcm.edu.cn
- Phone: (+86)0591-22861227
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Deep phenotyping to explore recovery in young adults after stroke
This project will test whether a detailed health and sample-collection approach (deep phenotyping) is practical and acceptable for people aged 18–55 who have had a stroke.
-
Stem cell therapy for chronic stroke recovery
This study is testing whether using a patient's own stem cells can help people with long-term stroke recovery feel better and improve their daily functioning.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
-
Web-based therapy using action observation and mirror therapy for arm weakness after stroke
This trial tests whether a mobile telerehabilitation app delivering action observation therapy (AOT) alone or combined AOT with mirror therapy (AOT-MT) can improve upper limb function in people with subacute stroke.
-
Remote Ischaemic Conditioning for Fatigue After Stroke 2
Aat least 12 weeks after stroke, adults with post-stroke fatigue will try a simple hand-arm cuff treatment at home to see if it helps reduce fatigue.
-
Dual-task balance training plus computer-based cognitive training after stroke
In adults who recently had a stroke, the study tests whether adding computerized cognitive exercises to balance training improves balance and other recovery outcomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.